i) blood cultures: Gram-positive 51%, Gram-negative 44%, mixed 5%, fungi 0%; ii) Septifast: Gram-positive 27%, Gram-negative 59%, mixed 8%, fungi 6%. Using blood cultures as reference, sensitivity of Septifast PCR was 38% (13% in Gram-positive, 57% in Gramnegative), specificity 64%, PPV 26%, NPV 76%. 39% of pathogens not detected by Septifast were not included in the test spectrum. Performance of blood cultures and Septifast PCR in different settings are shown in the Conclusions: This pilot study suggests that Septifast PCR blood assay may be an efficient tool for the early diagnosis of invasive mycoses in neutropenic patients with acute leukemia. Excellent test' s specificity and negative predictive value might contribute to targeted use of antifungal therapy.
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